Stem cell apoptosis in HIV-1 alopecia

Journal of Cutaneous Pathology

Volumn 33, Issue 10, 2006, Pages 667-671

  Barcaui, Carlos Baptista ^a,c   Gonçalves Da Silva, Ana Maria ^a   Sotto, Mírian N ^a   Genser, Bernd ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Federal University of Bahia ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CELL MARKER; CYTOKERATIN 19; INDINAVIR; MONOCLONAL ANTIBODY; PROTEINASE INHIBITOR; VPR PROTEIN;

ADULT; ALOPECIA; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; FOLLICULITIS; HAIR FOLLICLE; HAIR GROWTH; HAIR ROOT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; NICK END LABELING; NONHUMAN; PATHOGENESIS; SIGNAL TRANSDUCTION; STEM CELL;

EID: 33749574109     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00517.x     Document Type: Article

References (31)

1. Calista D, Morri M, Stagno A, Boschini A. Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor. Am J Clin Dermatol 2002; 3: 59.
2. Wiwanitkit V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases. Int J Dermatol 2004; 43: 265.
3. Calista D, Boschini A. Cutaneous side effects induced by indinavir. Eur J Dermatol 2000; 10: 292.
4. Smith KJ, Skelton HG, De Russo D, et al. Clinical and histological features of hair loss in patients with HIV-1 infection. J Am Acad Dermatol 1996; 34: 63.
5. Paus R, Muller-Rover S, van der Veen C, et al. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999; 113: 523.
6. Muller-Rover S, Rossiter H, Lindner G, Peters E. Hair follicle apoptosis and Bcl-2. J Invest Dermatol 1999; 4: 272.
7. Cotsarelis G, Tung-Tien S, Lavker RM. Label retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle and skin carcinogenesis. Cell 1990; 61: 1329.
8. Ito M, Kizawa K, Iiamada K, Cotsarelis G. Hair follicle stem cells in the lower bulge from the secondary germ, a biochemically distinct but functionally equivalent progenitor cell population, at termination of catagen. Differentiation 2004; 72: 548.
9. Ito M, Kizawa K, Toyoda M, Morohashi M. Label retaining cells in the bulge region are directed to cell death after plucking, followed by healing from the surviving hair germ. J Invest Dermatol 2002; 119: 1310.
10. Sale GE, Beauchamp MD, Akiyama M. Parafollicular bulges, but not hair bulb keratinocytes, are attacked in graft-versus-host disease of human skin. Bone Marrow Transplant 1994; 14: 411.
11. Murphy GF, Lavker RM, Whitaker D, Korngold R. Cytotoxic folliculitis in GvHD: evidence of follicular stem cell injury and recovery. J Cutan Pathol 1991; 18: 309.
12. Headington JT. Transverse microscopy anatomy of the human scalp. A basis for a morphometric approach to disorders of the hair follicle. Arch Dermatol 1984; 120: 449.
13. Narisawa Y, Hashimoto K, Khoda H. Immunohistochemical demonstration of keratin 19 expression in isolated human hair follicles. J Invest Dermatol 1994; 103: 191.
14. Michel M, Torok N, Godbout MJ, et al. Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 1996; 109: 1017.
15. Stasiak PC, Purkis PE, Leigh IM, et al. Keratin 19: predicted aminoacid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 1989; 92: 707.
16. Christofidou-Solomidou M, Liu Y, Elder DE, Abelda S, Cotsarelis G. Human hair follicle bulge cells are biochemically distinct and possess an epithelial stem cell phenotype. J Investig Dermatol Symp Proc 1999; 4: 296.
17. Templeton SF, Santa Cruz DJ, Soloman AR. Alopecia: histologic diagnosis by transverse sections. Semin Diagn Pathol 1996; 2: 18.
18. Bouscarat F, Prevot M, Sophie M. Alopecia associated with indinavir therapy. N Eng J Med 1999; 341: 618.
19. Colebunders R, Bottieau E, de Mey I. Curly hair and lipodystrophy as a result of highly antiretroviral treatment? Arch Dermatol 2000; 136: 1064.
20. Harry TC, Mathews M, Salvary I. Indinavir use: associated reversible hair loss and mood disturbance. Int J STD AIDS 2000; 474: 6.
21. Ginarte M, Losada E, Prieto A, Lorenzo-Zuniga V. Generalized hair loss induced by indinavir plus ritonavir therapy. AIDS 2002; 1695: 96.
22. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355.
23. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675.
24. Darnay BG, Aggarwal BB. Early events in TNF signaling: a story of associations and dissociations. J Leukoc Biol 1997; 61: 559.
25. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673.
26. Soengas MS, Alarcon RM, Yoshida H, et al. Apaf-1 and caspase-9 in p53 dependent apoptosis and tumor inhibition. Science 1999; 284: 156.
27. Badley A, Pilon A, Landay A, Lynch D. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000; 96: 2951.
28. Basañez G, Zimmerberg J. HIV and apoptosis: death and the mitochondrion. J Exp Med 2001; 193: 11.
29. Agostini I, Popov S, Li J, Dubrovsky L, Hao T, Bukrinsky M. Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. Exp Cell Res 2000; 259: 398.
30. Stewart SA, Poon B, Song JY, Chen IY. Human Immunodeficiency virus type 1 Vpr induces apoptosis through caspase activation. J Virol 2000; 3105: 11.
31. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D. Neuronal apoptosis induced by Tat protein and TNF-α: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 1998; 4: 281.